甲状腺功能亢进治疗期间血清长效甲状腺刺激素含量与甲状腺抑制性的分离 - Suppr | 超能文献

Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.

作者信息

Chopra I J, Solomon D H, Johnson D E, Chopra U, Fischer D A

出版信息

J Clin Endocrinol Metab. 1970 Apr;30(4):524-8. doi: 10.1210/jcem-30-4-524.

DOI:10.1210/jcem-30-4-524

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.甲状腺功能亢进治疗期间血清长效甲状腺刺激素含量与甲状腺抑制性的分离

J Clin Endocrinol Metab. 1970 Apr;30(4):524-8. doi: 10.1210/jcem-30-4-524.

2

Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.硫酰胺类药物治疗甲亢患者时甲状腺刺激物与3,5,3'-三碘甲状腺原氨酸抑制性之间的相关性：基于甲状腺刺激活性和促甲状腺激素替代活性检测方法的比较

J Clin Endocrinol Metab. 1979 Apr;48(4):706-11. doi: 10.1210/jcem-48-4-706.

3

Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.甲状腺毒症患者的垂体-甲状腺功能与长效甲状腺刺激素（LATS）水平的关系。

Acta Endocrinol (Copenh). 1970 Dec;65(4):577-82. doi: 10.1530/acta.0.0650577.

4

Thyroid gland in Graves' disease: victim or culprit?格雷夫斯病中的甲状腺：受害者还是罪魁祸首？

Metabolism. 1970 Oct;19(10):760-72. doi: 10.1016/0026-0495(70)90074-0.

5

Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.甲状腺功能亢进症抗甲状腺药物治疗后促甲状腺激素释放激素反应性与甲状腺抑制性的分离

J Clin Endocrinol Metab. 1976 Sep;43(3):543-9. doi: 10.1210/jcem-43-3-543.

6

Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.甲状腺毒症中的甲状腺抑制性及长效甲状腺刺激素

Arch Intern Med. 1970 Oct;126(4):615-20.

7

Hyperthyroidism and excessive thyrotropin secretion.甲状腺功能亢进与促甲状腺素分泌过多。

N Engl J Med. 1972 Aug 17;287(7):328-33. doi: 10.1056/NEJM197208172870704.

8

[Frequency of recurrence following treatment of hyperthyroidism with methimazole and suppressibility of the thyroid gland (author's transl)].甲巯咪唑治疗甲状腺功能亢进症后的复发频率及甲状腺的抑制性（作者译）

Munch Med Wochenschr. 1973 Dec 7;115(49):2216-8.

9

Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.补充碘后塔斯马尼亚的甲状腺功能亢进：促甲状腺自身抗体和促甲状腺激素的测量

J Clin Endocrinol Metab. 1975 Aug;41(2):221-8. doi: 10.1210/jcem-41-2-221.

10

Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.尽管长效甲状腺刺激素水平很高，但甲状腺功能仍具有可抑制性。

Ann Intern Med. 1972 Jan;76(1):77-84. doi: 10.7326/0003-4819-76-1-77.

引用本文的文献

1

The application of a cytochemical bioassay to measure thyroid stimulating antibodies; a study of patients with euthyroid Graves' ophthalmopathy.应用细胞化学生物测定法测量促甲状腺抗体；对甲状腺功能正常的格雷夫斯眼病患者的研究。

J Endocrinol Invest. 1984 Dec;7(6):597-602. doi: 10.1007/BF03349492.

2

The long-acting thyroid stimulator.长效甲状腺刺激素

J R Coll Physicians Lond. 1972 Apr;6(3):309-15.

3

Thyroid suppressibility: follow-up for two years after antithyroid treatment.甲状腺抑制性：抗甲状腺治疗后两年的随访

Br Med J. 1971 Apr 3;2(5752):19-22. doi: 10.1136/bmj.2.5752.19.